Development of AAV-GBA1 Gene Replacement Therapy via Single-IV-Delivery with a Blood Brain Barrier Penetrant AAV Capsid

被引:0
|
作者
Chung, Charlotte [1 ]
Retzlaff, Cassie [1 ]
Thompson, Jeff [1 ]
Bloedel, Alexis [1 ]
Bruce, Amy [1 ]
Ecker, Abigail [1 ]
Clement, Joseph [1 ]
Knoll, Elisabeth R. [1 ]
Ezell, Brian C. [1 ]
Hoffman, Brett [1 ]
Knox, Tatiana [1 ]
Nonnenmacher, Mathieu E. [1 ]
Moyer, Tyler [1 ]
Lin, Jing [1 ]
Grant, Kyle [1 ]
Paranjpe, Maneesha [1 ]
Pande, Nilesh [1 ]
Johnson, Amy [1 ]
Yao, Johnny [1 ]
Sadhu, Chanchal [1 ]
Carter, Todd A. [1 ]
机构
[1] Voyager Therapeut, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
695
引用
收藏
页码:347 / 347
页数:1
相关论文
共 32 条
  • [31] Efficient Delivery of FMR1 across the Blood Brain Barrier Using AAVphp Construct in Adult FMR1 KO Mice Suggests the Feasibility of Gene Therapy for Fragile X Syndrome
    Chadman, Kathryn K.
    Adayev, Tatyana
    Udayan, Aishwarya
    Ahmed, Rida
    Dai, Chun-Ling
    Goodman, Jeffrey H.
    Meeker, Harry
    Dolzhanskaya, Natalia
    Velinov, Milen
    GENES, 2023, 14 (02)
  • [32] Danon Disease Phase 1 RP-A501 Results: The First Single-Dose Intravenous (IV) Gene Therapy with Recombinant Adeno-Associated Virus (AAV9:LAMP2B) for a Monogenic Cardiomyopathy
    Greenberg, Barry
    Rossano, Joseph
    Taylor, Matthew
    Adler, Eric D.
    Lin, Kimberly Y.
    Eshraghian, Emily
    Attias, Jennifer
    Hong, Kimberly N.
    Urey, Marcus Anthony
    Shah, Monica
    Ricks, David
    Yarabe, Paul
    Schwartz, Jonathan
    MOLECULAR THERAPY, 2023, 31 (04) : 6 - 6